Lucid Diagnostics Inc.

NASDAQ:LUCD

1.1 (USD) • At close July 1, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42018 Q4
Revenue 0.8281.1971.1720.9761.0011.040.7830.1590.4460.1120.07600.1890.30.200000000
Cost of Revenue 1.5512.1451.6841.6141.6561.4571.6341.5491.3381.6181.6260.7040.3690.4410.14400.003000000
Gross Profit -0.723-0.948-0.512-0.638-0.655-0.417-0.851-1.39-0.892-1.506-1.55-0.704-0.18-0.1410.056-0-0.003000000
Gross Profit Ratio -0.873-0.792-0.437-0.654-0.654-0.401-1.087-8.742-2-13.446-20.3950-0.952-0.4710.27900000000
Reseach & Development Expenses 1.4281.4531.6661.3721.5011.9181.6151.8271.8932.4422.7043.442.8813.4822.191.8731.7521.8261.2160.8661.5341.8220.645
General & Administrative Expenses 6.1625.8645.3554.8674.074.2054.323.836.95.4625.667.3115.8924.9854.3763.1221.2120.9050.8050.4440.68300.417
Selling & Marketing Expenses 4.0694.0044.0564.214.1944.4083.8374.0324.1275.0133.933.8733.3185.260.9181.0210.6890.6330.3350000
SG&A 10.2319.8689.4119.0778.2648.6138.1577.73410.53110.4759.5910.5499.217.6184.3764.1431.9010.9050.8050.4440.683-0.1640.417
Other Expenses 0.1050.1060.1050.1050.3720.540.5050.5050.5050.5050.5050.639-0.1730000000000
Operating Expenses 11.76411.42711.18210.55410.13711.03610.27710.19413.42513.42212.79913.9212.09111.16.5666.0163.6532.7312.0221.312.2171.6581.062
Operating Income -12.487-12.375-11.694-11.192-10.792-11.453-11.128-11.584-14.317-14.928-14.377-14.628-12.271-11.24-6.51-6.016-3.653-2.731-2.022-1.31-2.217-1.658-1.062
Operating Income Ratio -15.081-10.338-9.978-11.467-10.781-11.013-14.212-72.855-32.101-133.286-189.1710-64.926-37.468-32.5500000000
Total Other Income Expenses Net -14,4210.834-0.6770.1870.180.623-3.080.203-1.93000.0040.001-0.065-0.447-0.1470000000
Income Before Tax -26.908-11.541-12.371-11.005-10.612-10.83-14.208-11.381-16.247-14.928-14.349-14.624-12.27-11.306-6.957-6.163-3.653-2.731-2.022-1.31-2.217-1.658-1.062
Income Before Tax Ratio -32.498-9.642-10.555-11.276-10.601-10.413-18.146-71.579-36.428-133.286-188.8030-64.921-37.685-34.78300000000
Income Tax Expense 9,1107,496007,496-1,960.351-2.8720.2231,963-0.1730.5660.0040.1730.0650.4470.1470-2.731-2.0220000
Net Income -26.908-11.541-12.371-11.005-10.612-10.83-14.208-11.381-1,979.247-14.755-14.349-14.624-12.27-11.306-6.957-6.163-3.653-2.731-2.022-1.31-2.217-1.658-1.062
Net Income Ratio -32.498-9.642-10.555-11.276-10.601-10.413-18.146-71.579-4,437.774-131.741-188.8030-64.921-37.685-34.78500000000
EPS -0.52-0.2-0.25-0.23-0.4-0.26-0.34-0.27-48.31-0.4-0.39-0.41-0.35-0.31-0.19-0.17-0.099-0.074-0.055-0.093-0.16-0.045-0.075
EPS Diluted -0.52-0.2-0.25-0.23-0.4-0.26-0.34-0.27-48.31-0.4-0.39-0.41-0.35-0.31-0.19-0.17-0.099-0.074-0.055-0.093-0.16-0.045-0.075
EBITDA -26.678-11.312-12.155-10.77-10.099-10.19-13.434-10.525-15.602-14.313-13.756-13.92-12.246-11.24-6.51-6.016-3.65-2.731-2.02200-1.6580.563
EBITDA Ratio -32.22-9.45-10.371-11.035-10.089-9.798-17.157-66.195-34.982-127.795-1810-64.794-37.466-32.5500000000